These findings show the essential role of USP25 in adipocyte differentiation and lipid metabolism, suggesting that targeting USP25 ablation in adipocytes could be a promising therapeutic strategy for obesity treatment. Here, USP25 is linked to obesity due to melanocortin 4 receptor deficiency.